Abstract B003: Validating PTPN22 as a cancer-agnostic immunotherapeutic target
Year: 2024
Type: conference-abstract
Source: Cancer Immunology Research
Institutions: Johns Hopkins University, Purdue University West Lafayette
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4403520134
